This cancer-drug maker has a novel medicine with the possibility for extraordinary growth.
News & Analysis: Karyopharm Therapeutics
KPTI earnings call for the period ending December 31, 2019.
Risk-taking investors flock to biotech for its constant flow of events that can spike or crush the stock prices of the companies developing the latest therapies.
Early next year, Karyopharm expects to unveil pivotal clinical trial results that could send shares soaring.
KPTI earnings call for the period ending September 30, 2019.
KPTI earnings call for the period ending June 30, 2019.
Shares jump after the biopharma receives some praise from Wall Street.
Traders cheer after the company reports a regulatory win.
Markets rose in a shortened pre-holiday trading session.
KPTI earnings call for the period ending March 31, 2019.